Refine your search with our Advanced Search Tool
Listing contains 128 trial(s)
Esophageal Cancer
Quality of Life Study
Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy & Quality of Life Study Number: 98-075 |
Tissue and/or blood banking study
Esophageal Cancer Registry Study Number: 98-122 |
Lung Cancer, Non-Small Cell
Lab
Detection of Genetic Markers of Lung Cancer Initiation and Progression Study Number: 99-053 |
CTP (Computed Tomography Perfusion) Imaging of Lung Cancer Study Number: 08-149 |
Phase I
Active Immunization of Patients with Non Small Cell Lung Cancer (NSCLC) Using Fibroblasts Transfected with DNA from Autologous Tumor (Phase IB Study) Study Number: 08-004 |
Phase I/II
Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Maganese Superoxided Dismutase (MnSOD) Plasmid Liposome (PL) Protection in Patients with Locally Advanced Stage III Non-Small Lung Cancer A Phase I-II Study Study Number: 01-054 |
Phase II
A Phase II Study of Cetuximab in Combination with External Beam Radiation Followed by Consolidation Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Study Number: 05-106 |
Phase I/ II Study of Pemetrexed and LBH589 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer Study Number: 08-036 |
Phase III
A Randomized Phase III Study of Sublobar Resection versus Sublobar Resection plus Brachytherapy in High RiskPatients with Non-Small Cell Lung Cancer (NSCLC), 3 cm or smaller Study Number: 04-086 |
A Prospective Evaluation of Outcomes of Radiosurgical Treatment of Non-Small Cell Lung Cancer (NSCLC) and Pulmonary Metastatses Study Number: 05-116 |
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast, and Prostate Cancer (RTOG 0517) Study Number: 07-114 |
A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (< 2cm) Peipheral Non-small Cell Lung Cancer Study Number: 07-150 |
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC) Study Number: 07-151 |
Pilot
LIFE-Lung Fluorescence Endoscopic Surveillance in Patients at High Risk For Developing Lung Cancer Study Number: 98-021 |
Outcome Evaluation of Radiofrequency Ablation of Lung Tumors Study Number: 02-033 |
Lung Cancer, Small Cell
Phase I/II
Phase I/ II Trial of Carboplatin and Etoposide Plus LBH589 in Extensive Stage Small Cell Lung Cancer Study Number: 08-035 |
Phase III
A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy Study Number: 08-116 |
Peritoneal Cavity Cancer
Lab
Novel Risk Factors and Potential Early Detection Markers for Ovarian Cancer HOPE (Hormones and Ovarian Cancer Prediction) Study Number: 04-032 |
Prospective/Retrospective Study
A Non-Interventional Prospective Study of the Accuracy of the Precision Therapeutics, Inc. ChemoResponse Assay in Patients with Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer (GOC 05-005) Study Number: 05-080 |
Tissue and/or blood banking study
GDP: Tissue and Data Acquisition Activity for the Study of Gynecologic Disease (GOC 04-124) Study Number: 04-124 |
